MaxWin International Holdings Limited
8513.HKHKSEHealthcareMedical - Instruments & Supplies
Latest quote
HK$0.305
−HK$0.015 · -4.69%
Aug 18, 3:54 PM HKTData delayed
8513.HK company overview
Historical prices · Market data may be delayed.
Company profile
IAG Holdings Limited functions as an investment holding company, primarily focusing on the manufacturing and sale of injection-molded plastic components for single-use medical devices. The company also provides specialized tooling services, involving the fabrication of molds critical for the injection molding process. Its plastic products encompass both individual parts and assembled sub-components, designed for a variety of medical applications such as respiratory, dialysis, blood bag, drug delivery, and diagnostic equipment. Major clients include prominent multinational medical device corporations based in the United States, Europe, and Japan.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- SG
- CEO
- Swee Hoe Phua
- Listed since
- Jan 19, 2018
- Employees
- 94
Market position
52-week range
Current HK$0.305
HK$0.305HK$1.57
- Open
- HK$0.305
- Previous close
- HK$0.32
- Volume
- 30K
- 2.24× average
- Average volume
- 13.42K
- Average daily volume
- Market cap
- 24.96M HKD
- Beta
- 0.14
- Market reference 1
- 50-day average
- HK$0.3693
- -17.41% below average
- 200-day average
- HK$0.6748
- -54.80% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 17.05M SGD
- P/E (TTM)
- -6.87×
- P/B (TTM)
- 2.49×
- P/S (TTM)
- 0.22×
- EV / EBITDA
- 28.52×
- Earnings yield
- -3.94%
- Free cash flow yield
- 1.55%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 16.56%
- Operating margin
- -1.73%
- Net margin
- -3.29%
- Return on equity
- -40.16%
- Return on assets
- -6.86%
- Return on invested capital
- -4.74%
Financial health
- Debt / equity
- 1.77×
- Current ratio
- 1.06×
- Altman Z-score
- -1.16
- Piotroski F-score
- 6 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Gross marginOperating marginNet margin
Income trends
Revenue
18.59M SGD+77.70%
Operating income
−322K SGD+87.70%
Net income
−612K SGD+76.74%
| Metric (SGD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18.59M SGD | 10.46M SGD | 9.15M SGD | 13.9M SGD | 19.77M SGD |
| Cost of goods sold | 15.51M SGD | 10.42M SGD | 9.88M SGD | 13.72M SGD | 15.8M SGD |
| Gross profit | 3.08M SGD | 44K SGD | −730K SGD | 938K SGD | 3.97M SGD |
| Research and development | 403K SGD | 559K SGD | 1.62M SGD | 291K SGD | 281K SGD |
| Selling, general, and administrative | 3.15M SGD | 2.79M SGD | 2.9M SGD | 2.52M SGD | 3.63M SGD |
| Operating expenses | 3.4M SGD | 2.66M SGD | 3.87M SGD | 2.33M SGD | 11.11M SGD |
| Interest expense | 274.04K SGD | 167K SGD | 159K SGD | 124K SGD | 241K SGD |
| Depreciation and amortization | 333K SGD | 636K SGD | 2.2M SGD | 479K SGD | 2.51M SGD |
| Operating income | −322K SGD | −2.62M SGD | −4.6M SGD | −2.16M SGD | −7.14M SGD |
| Net income | −612K SGD | −2.63M SGD | −6.75M SGD | −3.06M SGD | −7.05M SGD |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- -0.02
EPS: actual versus estimate
Recent quarterly results
ActualEstimate
Estimates unavailableRevenue: actual versus estimate
Recent quarterly results
ActualEstimate
Estimates unavailableCorporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jan 8, 2026 | 1:10 | — | — |
Stock split
Effective Jan 8, 2026
1:10
8513.HK peers
Continue in GoAI
Research 8513.HKresearch.disclaimer